Development of a Physiologically-Based Pharmacokinetic Model of Δ9-Tetrahydrocannabinol in Mice, Rats, and Pigs

被引:0
|
作者
Janthima Methaneethorn
Kanyamas Naosang
Parichart Kaewworasut
Chomkanang Poomsaidorn
Manupat Lohitnavy
机构
[1] Naresuan University,Pharmacokinetic Research Unit, Faculty of Pharmaceutical Sciences
[2] Naresuan University,Center of Excellence for Environmental Health and Toxicology
[3] Naresuan University,Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:487 / 494
页数:7
相关论文
共 50 条
  • [41] Development of a physiologically based pharmacokinetic model for intravenous lenalidomide in mice
    Hughes, Jim H.
    Upton, Richard N.
    Reuter, Stephanie E.
    Rozewski, Darlene M.
    Phelps, Mitch A.
    Foster, David J. R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (05) : 1073 - 1087
  • [42] A behavioural model to reveal place preference to Δ9-tetrahydrocannabinol in mice
    Valjent, E
    Maldonado, R
    PSYCHOPHARMACOLOGY, 2000, 147 (04) : 436 - 438
  • [43] Development of a physiologically based pharmacokinetic model of organic solvent in rats
    Kaneko, T
    Horiuchi, J
    Sato, A
    PHARMACOLOGICAL RESEARCH, 2000, 42 (05) : 465 - 470
  • [44] DEVELOPMENT OF A PEDIATRIC BRAIN PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL IN CHILDREN WITH AND WITHOUT MENINGITIS.
    Verscheijden, L. F. M.
    Koenderink, J. B.
    Allegaert, K.
    de Wildt, S. N.
    Russel, F. G. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S74 - S74
  • [45] A behavioural model to reveal place preference to Δ9-tetrahydrocannabinol in mice
    E. Valjent
    R. Maldonado
    Psychopharmacology, 2000, 147 : 436 - 438
  • [46] Physiologically-based pharmacokinetic model of topical intravaginal HIV prevention
    Kay, Katherine
    Rohan, Lisa C.
    Shah, Dhavalkumar
    Bies, Robert
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S88 - S88
  • [47] Physiologically-based pharmacokinetic model for predicting blood and tissue concentrations
    Zhu, Leo
    Pei, William
    DiCiano, Patricia
    Brands, Bruna
    Wickens, Christine M.
    Le Foll, Bernard
    Kwong, Bronsen
    Parashar, Megha
    Sivananthan, Atchu
    Mahadevan, Radhakrishnan
    COMPUTERS & CHEMICAL ENGINEERING, 2021, 154
  • [48] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF METOCLOPRAMIDE IN SPECIAL POPULATIONS.
    Silva, L.
    Diniz, A.
    Martins, F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S10 - S10
  • [49] Physiologically-based pharmacokinetic (PBPK) model to describe the disposition of pyronaridine
    Diep, John K.
    Lingerfelt, Mary A.
    Ekins, Sean
    Rao, Gauri G.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S34 - S34
  • [50] Development of a physiologically based pharmacokinetic model for bisphenol A in pregnant mice
    Kawamoto, Yuko
    Matsuyama, Wakoto
    Wada, Masahiro
    Hishikawa, Junko
    Chan, Melissa Pui Ling
    Nakayama, Aki
    Morisawa, Shinsuke
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 224 (02) : 182 - 191